How Does FidoCure Work?
FidoCure is pioneering a revolutionary approach to treating canine cancer – bringing the power of precision medicine from human oncology to veterinary care. As the first and only service of its kind, FidoCure provides genomic testing to identify the unique genetic markers driving each dog’s cancer. This information can guide individualized treatment plans and leverage […]
Vet Optimist Podcast: Interview with CEO Christina K. Lopes and Jennifer Evans
We are excited to share an inspiring and insightful episode of “The Veterinary Optimist” podcast, featuring our very own Christina Lopes, CEO and Co-Founder of The One Health Company. In this special episode, Christina opens up about her journey, from her father’s battle with cancer to the loss of several beloved family dogs, and how […]
Companion Animal Science Takes Center Stage: Insights from The New York Times
A recent article in The New York Times, titled, “How science went to the dogs (and cats),” highlights the remarkable evolution of companion animal research over the past two decades. Once dismissed as trivial subjects, pets are now at the forefront of scientific inquiry, with researchers around the world delving deep into the bodies and […]
Precision Medicine for Canine Mammary Gland Tumors
Mammary tumors are common in intact female dogs, especially middle-aged and older dogs of smaller breeds like Poodles, Chihuahuas, and Dachshunds, though some larger breeds are also at higher risk. Hormonal exposure plays a key role, with dogs spayed before their first heat cycle having only a 0.5% risk. Treatment typically involves surgical removal, which […]
Histiocytic Sarcoma: One of the Most Aggressive Cancers
Histiocytic sarcoma (HS) is an aggressive cancer originating from white blood cells called histiocytes that are involved in the immune system. There are three main forms, (1) localized, which presents, at least initially, at a single site such as the bones, joints, or lungs, (2) disseminated, which involves multiple organ systems at diagnosis, and (3) […]
Canine Melanoma: A Common, Aggressive Malignancy
Melanoma is an aggressive cancer arising from pigment-producing cells, accounting for 7% of canine tumors with certain breeds at higher risk. The most common form is oral melanoma, which affects the mouth and gums, and has the potential to metastasize. Cutaneous melanomas can also occur but are less common than oral melanomas and are often […]
Rounding Out National Cancer Research Month
As we round out National Cancer Research Month, we want to highlight the important work being done by FidoCure researchers in comparative oncology. At FidoCure, we’ve pioneered canine cancer research backed by real-world evidence and published our findings in 4 of the most prestigious peer-reviewed scientific journals. Many of these papers are go-to sources for […]
FidoCure Brings Precision Medicine to the Forefront of Canine Cancer
One out of four pet dogs will be diagnosed with cancer throughout their lifetime. With nearly 6 million new canine cancer diagnoses each year, there is an urgent need for advanced treatments. Fortunately, FidoCure introduces advanced options into the cancer treatment toolbox for veterinarians and dogs, offering hope for improved outcomes.
Small Molecules, Big Impact: An Interview with Dr. Cheryl London
Explore the history and impact of small molecules in this fascinating discussion. FidoCure’s Chief Medical Officer, Dr. Gerry Post interviews Dr. Cheryl London about their application in canine cancer treatment. Dr. Cheryl London is a world-renowned expert in veterinary oncology and targeted cancer therapies at Tufts University. Her pioneering work began in 2000 when she […]
Understanding Hemangiosarcoma in Dogs: Treatment Options and Prognosis
Hemangiosarcoma is an aggressive, malignant tumor derived from blood vessel cells that grows rapidly, can cause severe bleeding, and has a high metastasis rate. It most commonly affects the spleen but can also occur in the heart, skin, and liver, with certain breeds like German Shepherds, Golden Retrievers, and Labradors at higher risk. Treatment typically […]
